137 related articles for article (PubMed ID: 36467365)
1. Polymorphisms in drug metabolism genes predict the risk of refractory myasthenia gravis.
Zhang Q; Ge H; Gui M; Yang M; Bi Z; Ma X; Gu Z; Peng S; Chen T; Bu B
Ann Transl Med; 2022 Nov; 10(21):1155. PubMed ID: 36467365
[TBL] [Abstract][Full Text] [Related]
2. CYP3A7, CYP3A4, and CYP3A5 genetic polymorphisms in recipients rather than donors influence tacrolimus concentrations in the early stages after liver transplantation.
Dong Y; Xu Q; Li R; Tao Y; Zhang Q; Li J; Ma Z; Shen C; Zhong M; Wang Z; Qiu X
Gene; 2022 Jan; 809():146007. PubMed ID: 34688813
[TBL] [Abstract][Full Text] [Related]
3. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
[TBL] [Abstract][Full Text] [Related]
4. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH
Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms of HSP90AA1 gene influence response of SLE patients to glucocorticoids treatment.
Zou YF; Xu JH; Gu YY; Pan FM; Tao JH; Wang DG; Xu SQ; Xiao H; Chen PL; Liu S; Cai J; Lian L; Liu SX; Liang CM; Tian G; Ye QL; Pan HF; Su H; Ye DQ
Springerplus; 2016; 5():222. PubMed ID: 27026916
[TBL] [Abstract][Full Text] [Related]
6. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
Staatz CE; Goodman LK; Tett SE
Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
[TBL] [Abstract][Full Text] [Related]
7. Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer.
Cantara S; Dalmiglio C; Marzocchi C; Sagnella A; Brilli L; Trimarchi A; Maino F; Valerio L; Castagna MG
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982571
[TBL] [Abstract][Full Text] [Related]
8. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
Staatz CE; Goodman LK; Tett SE
Clin Pharmacokinet; 2010 Mar; 49(3):141-75. PubMed ID: 20170205
[TBL] [Abstract][Full Text] [Related]
9. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia.
Harivenkatesh N; Kumar L; Bakhshi S; Sharma A; Kabra M; Velpandian T; Gogia A; Shastri SS; Biswas NR; Gupta YK
Pharmacol Res; 2017 Jun; 120():138-145. PubMed ID: 28330783
[TBL] [Abstract][Full Text] [Related]
10. [Association of CYP2C19 and CYP3A5 gene polymorphisms with myocardial infarction].
Qi L; Liang W; Qiao H; Wang R; Han J; Xing X; Hu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jan; 38(1):87-91. PubMed ID: 33423267
[TBL] [Abstract][Full Text] [Related]
11. Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients.
Tamashiro EY; Felipe CR; Genvigir FDV; Rodrigues AC; Campos AB; Hirata RDC; Tedesco-Silva H; Medina-Pestana JO
Drug Metab Pers Ther; 2017 May; 32(2):89-95. PubMed ID: 28593920
[TBL] [Abstract][Full Text] [Related]
12. Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients.
Berno G; Zaccarelli M; Gori C; Tempestilli M; Pucci L; Antinori A; Perno CF; Pucillo LP; D'Arrigo R
J Int AIDS Soc; 2014; 17(4 Suppl 3):19589. PubMed ID: 25394094
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of ALOX5AP and CYP3A5 increase susceptibility to ischemic stroke and are associated with atherothrombotic events in stroke patients.
Yi X; Zhang B; Wang C; Liao D; Lin J; Chi L
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):521-9. PubMed ID: 25534367
[TBL] [Abstract][Full Text] [Related]
14. Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants.
Yoon HY; Song TJ; Yee J; Park J; Gwak HS
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145636
[No Abstract] [Full Text] [Related]
15. The rs776746 variant of CYP3A5 is associated with intravenous midazolam plasma levels and higher clearance in critically ill Mexican paediatric patients.
Flores-Pérez C; Castillejos-López MJ; Chávez-Pacheco JL; Dávila-Borja VM; Flores-Pérez J; Zárate-Castañón P; Acosta-Bastidas M; Cruz-Escobar J; Torres-Espíndola LM
J Clin Pharm Ther; 2021 Jun; 46(3):633-639. PubMed ID: 33638195
[TBL] [Abstract][Full Text] [Related]
16. Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions.
Gao B; Tan T; Cao X; Pan M; Yang C; Wang J; Shuai Z; Xia Q
BMC Med Genomics; 2022 Feb; 15(1):23. PubMed ID: 35135554
[TBL] [Abstract][Full Text] [Related]
17. Correlations of TNF-α gene promoter polymorphisms with the risk of thymoma-associated myasthenia gravis in a northern Chinese Han population.
Yang HW; Lei P; Xie YC; Han ZL; Li D; Wang SH; Sun ZL
Cancer Gene Ther; 2017 Jun; 24(6):259-266. PubMed ID: 28429750
[TBL] [Abstract][Full Text] [Related]
18. Interaction between SELP genetic polymorphisms with inflammatory cytokine interleukin-6 (IL-6) gene variants on cardiovascular disease in Chinese Han population.
Kou L; Yang N; Dong B; Li Y; Yang J; Qin Q
Mamm Genome; 2017 Oct; 28(9-10):436-442. PubMed ID: 28819827
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-9 gene polymorphisms and their interaction with environment on subarachnoid hemorrhage risk.
Wang T; Fu W; Song S; Han Y; Yao L; Lu Y; Zheng J; Wang J
Exp Biol Med (Maywood); 2018 May; 243(9):749-753. PubMed ID: 29763368
[TBL] [Abstract][Full Text] [Related]
20. Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis.
Yan M; Fan X; Si H; Wang X; Wang Z; Wang Z; Lv X; Yin H; Jia Y; Jiang L; Xia Y; Liu Y
Cancer Chemother Pharmacol; 2022 Feb; 89(2):173-181. PubMed ID: 34988655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
